AUG 10, 2026 · JOURNAL ARTICLE
Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy
Biomarker Research
Preclinical mechanistic study in transgenic mice and PDX models with a novel protein delivery approach; no clinical efficacy data or human trials reported, only mechanism validation and proof-of-concept in xenografts.
Study details
DesignPreclinical mechanistic study in transgenic…
InterventionTargeted RBM38 expression in breast tissue;…
ComparatorDoxorubicin co-administration (for cardioto…